NCT04568889 is a NA clinical trial of A $10 Survey Incentive in Covid19, sponsored by Harvard University.

Who is sponsoring NCT04568889?

NCT04568889 is sponsored by Harvard University.

What drugs are being tested in NCT04568889?

Interventions in NCT04568889: A $10 Survey Incentive, A $20 Survey Incentive, Emphasis of Government Involvement, Emphasis of Academic Researchers Involvement, Cost-Benefit Frame, Duty Frame, Racial/Ethnic Frame, No Messaging.

What condition does NCT04568889 study?

NCT04568889 studies Covid19, Infectious Disease.

Is NCT04568889 still recruiting?

NCT04568889 is currently completed. Last updated 14 October 2022.

Last reviewed 2022-10-14 · How we verify

NCT04568889

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Minnesota COVID-19 Testing Project

Completed NA Last updated 14 October 2022

What this trial tests

NA trial testing A $10 Survey Incentive in Covid19 in 561 participants. Completed in 31 August 2022.

Timeline

28 September 2020

Primary endpoint
31 August 2022

31 August 2022

Quick facts

Lead sponsor	Harvard University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	561
Start date	28 September 2020
Primary completion	31 August 2022
Estimated completion	31 August 2022
Sites	10 locations across United States

Drugs / interventions tested

A $10 Survey Incentive
A $20 Survey Incentive
Emphasis of Government Involvement
Emphasis of Academic Researchers Involvement
Cost-Benefit Frame
Duty Frame
Racial/Ethnic Frame
No Messaging

Conditions studied

Covid19 — all drugs for Covid19 →
Infectious Disease — all drugs for Infectious Disease →

Sponsor

Harvard University

Who can join

18 and older, any sex, with Covid19 or Infectious Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this project is to help the state of Minnesota understand why individuals are not getting tested and potentially identify trusted individuals or organizations that could be used in follow-up work to send messages. Investigators focus on the first two issues of unit and item nonresponse, which is not random across the population and thus could lead to nonresponse bias. To do so, investigators are deploying flyers through 10 Twin City area food shelves and potentially through public housing units with information on how to answer an online questionnaire.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Harvard University trials

Trials by the same sponsor.

NCT07316647 — Using Conversational AI to Teach Growth Mindset Skills to Youths in India · NA · completed
NCT06114862 — Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 2) · NA · withdrawn
NCT07394465 — First Tones: Artistic Communal Practices for 4 and 5 Year Old Children · NA · completed
NCT06217705 — Testing the Effects of Project Calm in Ukrainian Schools · NA · completed
NCT06114875 — Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 1) · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04568889 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Harvard University
Last refreshed: 14 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04568889.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing